Semaglutide is gaining traction as a promising treatment for chronic diseases. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist works by stimulating the pancreas to secrete more insulin and reducing glucagon production. , Additionally, , semaglutide displays potential appli… Read More